MedPath

The effect of Artichoke Leaf Extract in the patients with Non Alcoholic Steatohepatitis (NASH).

Not Applicable
Conditions
non alcoholic steatohepatitis.
Fatty (change of) liver, not elsewhere classified
Registration Number
IRCT2014070218321N1
Lead Sponsor
Qazvin University of Medical Sciences, Faculty of Health
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Abnormal serum transaminases = 30 U/L ; Fatty liver in ultrasonography; At least one of the following, FBS greater than 100 mg/dL or a previous diagnosis of type II diabetes,obesity ( Body mass index of 30 or higher ),Blood pressure greater than 130/85 ,Triglyceride-levels greater than 150 mg/dl ,HDL-cholesterol lower than 40 mg/dl (men) and 50 mg/dl (women) ,Total cholesterol greater than 200 mg/dl.
Exclusion criteria:Daily alcohol consumption;Type I diabetes;Concomitant liver diseases,Presence of HCV antibody or HBs antigen, auto-immune hepatitis, hemochromatosis, Wilson’s disease, alpha1 anti-trypsin deficiency, Biliary obstruction;Use of livergol,Vit E, Vit C,UDCA,Heptotoxic Drug;Treatment with a drug known to induce NASH (amiodarone,calcium channel blocker, tamoxifen), and oral anticoagulation;Decompensated cirrhosis;Serious disease limiting life expectancy;Pregnancy and lactation;people who are Allergy sensitive to the Asteraceae/Compositae family.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Alanine aminotransferase (ALT). Timepoint: before and after intervention. Method of measurement: IU/Lit.;Aspartate aminotransferas (AST). Timepoint: before and after intervention. Method of measurement: IU/Lit.
Secondary Outcome Measures
NameTimeMethod
Total cholestrol. Timepoint: before and after the intervention. Method of measurement: Mg/dL.;LDL-C. Timepoint: before and after the intervention. Method of measurement: Mg/dL.;HDL-C. Timepoint: before and after the intervention. Method of measurement: Mg/dL.;Triglycerid. Timepoint: before and after the intervention. Method of measurement: Mg/dL.;Fasting blood sugar. Timepoint: before and after the intervention. Method of measurement: Mg/dL.
© Copyright 2025. All Rights Reserved by MedPath